Clinical Trials in New York

Showing 6761-6780 of 22,668 trials

Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

NCT02202772

The investigators intend to evaluate the safety and toxicity proﬁle of intravesically administered multidrug regimen of Cabazitaxel, Cisplatin and Gemcitabine in treatment refractory Transitional Cell Carcinoma.The investigators propose to conduct a combined phase I trial to assess the safety, toxicity, and efﬁcacy of a novel multidrug intravesical regimen consisting of Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the treatment of BCG resistant non-muscle invasive urothelial carcinoma of the bladder. This phase I trial will have a combined dose and cycle-escalation scheme with enrollment of up to 24 patients.

Urothelial Carcinoma of the Urinary Bladder

Guarionex J. Decastro51 participantsStarted Dec 2014

New York, New York, United States

TERMINATED< 1 mile

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants

NCT02761187

The purpose of this study is to describe contemporary, real-world patterns of participant characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in participants with newly diagnosed \[ND\] multiple myeloma (MM) and participants with relapsed/refractory \[R/R\] MM.

Multiple Myeloma

Takeda4,253 participantsStarted Jul 2016

Little Rock, Arkansas, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +134 more locations

Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants

Find Trials by Condition in New York

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Battlefield Acupuncture Following Shoulder Surgery

ThRombosis ExclUsion STudy

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

Persona Partial Knee Clinical Outcomes Study

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies

Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction